Target emmetropia – Ocular surface stabilisation and achieving refractive success with a new presbyopia-correcting intraocular lens

Recent advancements in intraocular lens (IOL) technology enable us to cater to the visual needs of demanding patients. A 53-year-old woman presented with a history of using heavy eye makeup and bilateral Nuclear Sclerosis Grade II (NS-II) cataracts. On examination, corrected distance visual acuity in both eyes was 6/6 and near visual acuity was N6. Both eyes had grade II meibomitis and dry eye. Being hypermetropic, she wanted complete spectacle-independence. As a boutique owner, her visual demands included fine tailoring work. The decision to use a presbyopia-correcting IOL was deferred due to a diseased ocular surface. Spectacles were prescribed and meibomitis and dry eye were treated. Pentacam values and IOL master calculations changed during her treatment over 6 months. Finally, with a stable ocular surface, both eyes underwent surgery with Adtec Xtnd IOL and achieved uncorrected visual acuity of 6/6 N6. Refractive success can be achieved with modern presbyopia-correcting IOLs in demanding patients with ocular surface disease.